The impact of 5-alpha-reductase inhibitors on mortality in a prostate cancer chemoprevention setting: a meta-analysis

被引：0
|
作者：
Pedro Glusman Knijnik
Pietro Waltrick Brum
Eduardo Tosetto Cachoeira
Artur de Oliveira Paludo
Antônio Rebello Horta Gorgen
Lucas Medeiros Burttet
Jeruza Lavanholi Neyeloff
Brasil Silva Neto
机构：
[1] Universidade Federal do Rio Grande do Sul,Faculty of Medicine
[2] Hospital de Clínicas de Porto Alegre,Urology Department
[3] Hospital de Clínicas de Porto Alegre,undefined
来源：
World Journal of Urology | 2021年 / 39卷
关键词：
5-alpha-reductase inhibitors; Prostate cancer; Mortality; Incidence; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：365 / 376
页数：11
相关论文
共 50 条
  • [31] REGULATION OF DIHYDROTESTOSTERONE IN HUMAN-PROSTATE BY 5-ALPHA-REDUCTASE AND ITS INHIBITORS
    DUNSTANADAMS, E
    BRUCHOVSKY, N
    RENNIE, PS
    GOLDENBERG, L
    MCLOUGHLIN, M
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1985, 8 (03): : A81 - A81
  • [32] 5-alpha-reductase and the development of the human prostate
    Radmayr, C.
    Lunacek, A.
    Schwentner, C.
    Oswald, J.
    Klocker, H.
    Bartsch, G.
    INDIAN JOURNAL OF UROLOGY, 2008, 24 (03) : 309 - 312
  • [33] THE RISK OF FRACTURES WITH ALPHA BLOCKERS AND 5-ALPHA REDUCTASE INHIBITORS IN BENIGN PROSTATE HYPERPLASIA: A META-ANALYSIS
    Lim, S.
    Laengvejkal, P.
    Nugent, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (02) : 457 - 457
  • [34] NOVEL AROMATASE AND 5-ALPHA-REDUCTASE INHIBITORS
    DISALLE, E
    BRIATICO, G
    GIUDICI, D
    ORNATI, G
    ZACCHEO, T
    BUZZETTI, F
    NESI, M
    PANZERI, A
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 49 (4-6): : 289 - 294
  • [35] SEXUAL DYSFUNCTION IN SUBJECTS TREATED WITH INHIBITORS OF 5-ALPHA-REDUCTASE FOR BENIGN PROSTATIC HYPERPLASIA: A COMPREHENSIVE REVIEW AND META-ANALYSIS
    Maseroli, E.
    Corona, G.
    Santi, D.
    Gacci, M.
    Dicuio, M.
    Sforza, A.
    Mannucci, E.
    Maggi, M.
    Corona, G.
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (04): : E133 - E133
  • [36] Role of 5-alpha-reductase inhibitors in active surveillance of patients with low-risk prostate cancer
    Chiang, Andrew Szehsun
    Loblaw, D. Andrew
    Jethava, Vibhuti
    Sethukavalan, Perakaa
    Zhang, Liying
    Vesprini, Danny
    Mamedov, Alexandre
    Nam, Robert
    Klotz, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [37] 5-ALPHA-REDUCTASE - A NEW CLASS OF BIOLOGICAL MARKER FOR CANCER OF THE PROSTATE
    TANNENBAUM, M
    ANTICANCER RESEARCH, 1986, 6 (03) : 352 - 352
  • [38] 5α-Reductase Inhibitors Could Prevent the Clinical and Pathological Progression of Prostate Cancer: A Meta-analysis
    Yang, Yue
    Hu, Haifeng
    Zhang, Hanchao
    Liu, Zhengdao
    Zhao, Faliang
    Yang, Jin
    Liang, Guobiao
    UROLOGY JOURNAL, 2021, 18 (03) : 247 - 251
  • [39] 5-α Reductase Inhibitors and Prostate Cancer Mortality
    Hamilton, Robert J.
    Chavarriaga, Julian
    Khurram, Najia
    Lau, Cindy
    Luo, Jin
    Liu, Ning
    Komisarenko, Maria
    Kulkarni, Girish
    Wallis, Christopher
    Juurlink, David N.
    Fleshner, Neil
    Finelli, Antonio
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [40] Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality
    Bjornebo, Lars
    Nordstrom, Tobias
    Discacciati, Andrea
    Palsdottir, Thorgerdur
    Aly, Markus
    Gronberg, Henrik
    Eklund, Martin
    Lantz, Anna
    JAMA ONCOLOGY, 2022, 8 (07) : 1019 - 1026
12345